All In Biotech

Drug Trial Radar · NCT03864614

A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)

A Phase 3, Open-Label, 1-Year Study of the Safety, Tolerability, and Need for Re-Treatment With SAGE-217 in Adult Subjects With Major Depressive Disorder

Last checked: Nov 20, 2026Latest source record: Aug 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,515

Actual

Start

Feb 27, 2019

Primary completion

Jun 22, 2023

Study completion Jun 22, 2023

Sponsor

Lead sponsor
BiogenBiogen (BIIB)
Sponsor type
Industry
First posted
Mar 6, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3, open-label, 1-year study of the safety, tolerability, and need for re-treatment with SAGE-217 in adult participants with MDD.

Conditions

  • Major Depressive Disorder

Interventions

  • SAGE-217Drug

    SAGE-217

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A: Number of Participants With Treatment Emergent Adverse Events (TEAEs)Time frame: Up to 52 Weeks
  2. Part B: Number of Participants With TEAEsTime frame: Up to 46 Weeks
  3. Part A: Number of Participants With Suicidal Ideation (SI) or Suicidal Behavior (SB) as Assessed by the Columbia Suicide Severity Rating Scale (C-SSRS)Time frame: Baseline up to 52 Weeks (Study Period 1-5)
  4. Part B: Number of Participants With Suicidal Ideation (SI) and Suicidal Behavior (SB) as Assessed by the C-SSRSTime frame: Baseline up to 46 Weeks (Study Period 1-5)

Locations

52 sites in 1 country. Site status is shown where the registry gives one.

  • Sage Investigational Site

    Dothan, Alabama

  • Sage Investigational Site

    Phoenix, Arizona

  • Sage Investigational Site

    Anaheim, California

  • Sage Investigational Site

    Costa Mesa, California

  • Sage Investigational Site

    Glendale, California

  • Sage Investigational Site

    Irvine, California

  • Sage Investigational Site

    Los Alamitos, California

  • Sage Investigational Site

    Oceanside, California

  • Sage Investigational Site

    Orange, California

  • Sage Investigational Site

    Riverside, California

  • Sage Investigational Site

    San Diego, California

  • Sage Investigational Site

    Temecula, California

  • Sage Investigational Site

    Colorado Springs, Colorado

  • Sage Investigational Site

    Cromwell, Connecticut

  • Sage Investigational Site

    Norwich, Connecticut

  • Sage Investigational Site

    Coral Springs, Florida

  • Sage Investigational Site

    Jacksonville, Florida

  • Sage Investigational Site

    Miami, Florida

  • Sage Investigational Site

    Orlando, Florida

  • Sage Investigational Site

    Orlando, Florida

  • Sage Investigational Site

    Pensacola, Florida

  • Sage Investigational Site

    Alpharetta, Georgia

  • Sage Investigational Site

    Atlanta, Georgia

  • Sage Investigational Site

    Marietta, Georgia

  • Sage Investigational Site

    Savannah, Georgia

  • Sage Investigational Site

    Chicago, Illinois

  • Sage Investigational Site

    Chicago, Illinois

  • Sage Investigational Site

    Watertown, Massachusetts

  • Sage Investigational Site

    Ann Arbor, Michigan

  • Sage Investigational Site

    Saint Charles, Missouri

  • Sage Investigational Site

    Lincoln, Nebraska

  • Sage Investigational Site

    Cherry Hill, New Jersey

  • Sage Investigational site

    Marlton, New Jersey

  • Sage Investigational Site

    Princeton, New Jersey

  • Sage Investigational Site

    Albuquerque, New Mexico

  • Sage Investigational Site

    Brooklyn, New York

  • Sage Investigational Site

    Brooklyn, New York

  • Sage Investigational Site

    Mount Kisco, New York

  • Sage Investigational Site

    Beachwood, Ohio

  • Sage Investigational Site

    Cincinnati, Ohio

Showing 40 of 52 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.